1,228 results match your criteria Pacemakers and Implantable Cardioverter Defibrillators


Cardiac Resynchronization Therapy Using Pacemakers versus Defibrillators in Patients with Non-Ischemic Cardiomyopathy: The United States Experience from 2007 to 2014.

Heart Rhythm 2019 Apr 17. Epub 2019 Apr 17.

Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.

Background: The impact of implantable defibrillator therapy on outcomes of patients with non-ischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy (CRT) device is controversial.

Objective: To examine the outcomes of NICM patients who receive a CRT pacemaker (CRT-P) versus defibrillator (CRT-D).

Methods: Using 2007-2014 claims data for a 5% random sample of Medicare beneficiaries, we followed patients with NICM who received a CRT device (1,236 CRT-P and 4,359 CRT-D), excluding those with prior history of ventricular arrhythmias with a primary outcome of all-cause mortality and secondary outcomes including time to first cardiac hospitalization and total medical costs. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15475271193035
Publisher Site
http://dx.doi.org/10.1016/j.hrthm.2019.04.028DOI Listing
April 2019
1 Read

[Device-device interaction].

Herzschrittmacherther Elektrophysiol 2019 Apr 15. Epub 2019 Apr 15.

Med. Klinik I, Abteilung für Kardiologie und Angiologie, Universitätsklinik Gießen, UKGM, Klinikstraße 33, 35392, Gießen, Deutschland.

With a continuous increase in the approval of cardiac implantable electronic devices (CIED), not only pacemakers (PM) and implantable cardioverter defibrillators (ICD) but especially devices for treating chronic heart failure, more and more possibilities of device-device interactions arise, which in isolated cases can lead to death of the patient. Because of the still low numbers of patients overall, there are very few scientific studies and only isolated case reports on this topic. Devices which are at risk of interaction with a previously implanted PM are wearable cardioverter defibrillators (WCD) and subcutaneous ICDs (S-ICD). Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00399-019-0617-z
Publisher Site
http://dx.doi.org/10.1007/s00399-019-0617-zDOI Listing
April 2019
3 Reads

Cardiac Implantable Electronic Devices in Adults with Tetralogy of Fallot.

Am J Cardiol 2019 Mar 16. Epub 2019 Mar 16.

Department of Cardiovascular Medicine, Mayo Clinic Rochester, Minnesota.

Patient with repaired tetralogy of Fallot (TOF) sometimes require cardiac implantable electronic devices (CIED) for tachy/bradyarrhythmias. There are no population-based studies of CIED-related outcomes in the adult TOF population. We reviewed the Nationwide/National Inpatient Sample to determine trends in CIED-related admissions in adults with TOF repair. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029149193030
Publisher Site
http://dx.doi.org/10.1016/j.amjcard.2019.03.010DOI Listing
March 2019
2 Reads
3.276 Impact Factor

Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.

J Cardiovasc Electrophysiol 2019 Apr 2. Epub 2019 Apr 2.

Department of Internal Medicine, University of Hawaii, Honolulu, Hawaii.

Introduction: Recent studies suggest that implantable cardioverter defibrillators (ICDs) are associated with increased risk of cardiac implantable electronic device (CIED) infections when compared with permanent pacemakers (PPMs). However, there were controversies among studies. In this study we performed a systematic review and meta-analysis to explore the risk of device infection in ICD versus PPM. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jce.13932DOI Listing

Electrosurgery and Temperature Increase in Tissue With a Passive Metal Implant.

Front Surg 2019 12;6. Epub 2019 Mar 12.

Department of Plastic and Reconstructive Surgery, Oslo University Hospital Radiumhospitalet, Oslo, Norway.

During monopolar electrosurgery in patients, current paths can be influenced by metal implants, which can cause unintentional tissue heating in proximity to implants. Guidelines concerning electrosurgery and active implants such as pacemakers or implantable cardioverter defibrillators have been published, but most describe interference between electrosurgery and the active implant rather than the risk of unintended tissue heating. Tissue heating in proximity to implants during electrosurgery may cause an increased risk of patient injury. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fsurg.2019.00008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422872PMC
March 2019
2 Reads

Impact of cardiac resynchronisation therapy on cardiologists' exposure to radiation during implantation of pacemakers and implantable cardioverter-defibrillators.

J Radiol Prot 2019 Mar 26;39(2):489-497. Epub 2019 Mar 26.

Department of Cardiology, Reims University Hospital, Reims, France.

Cardiologists are among the health professionals that are most exposed to ionizing radiation, but there is no recent study quantifying overexposure of physicians during cardiac resynchronisation therapy (CRT) procedures compared to 'classical' implantation of pacemakers (PMs) or implantable cardioverter-defibrillators (ICDs). We aimed to measure and compare operator exposure to radiation during implantation of PM and ICD with or without CRT. The study population comprised all PMs and ICDs implanted in a large referral centre over a six months period. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6498/ab1377DOI Listing
March 2019
1 Read

Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?

Europace 2019 Mar 21. Epub 2019 Mar 21.

Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

Remote monitoring (RM) has become a new standard of care in the follow-up of patients with implantable pacemakers and defibrillators. While it has been consistently shown that RM enables earlier detection of clinically actionable events compared with traditional in-patient evaluation, this advantage did not translate into improved patient outcomes in clinical trials of RM except one study using daily multiparameter telemonitoring in heart failure (HF) patients. Therefore, this review, focusing on RM studies of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators in patients with HF, discusses possible explanations for the differences in trial outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euz011DOI Listing
March 2019
2 Reads

[Hacking into a pacemaker; risks of smart healthcare devices].

Ned Tijdschr Geneeskd 2019 Mar 8;163. Epub 2019 Mar 8.

UMC Utrecht, afd. Cardiologie.

Technological progress in healthcare offers a plethora of opportunities, but they also raise important issues, such as safety. Every year, around 18,000 electronic implants with a therapeutic function, such as pacemakers and implantable cardioverter defibrillators (ICDs), are implanted in patients in the Netherlands. Most of these devices are able to establish a wireless internet connection to share technical and diagnostic information remotely with healthcare providers. Read More

View Article

Download full-text PDF

Source
March 2019
1 Read

Percutaneous Microwave Tumor Ablation Is Safe in Patients with Cardiovascular Implantable Electronic Devices: A Single-Institutional Retrospective Review.

J Vasc Interv Radiol 2019 03;30(3):396-400

Department of Radiology, University of Wisconsin, 600 Highland Ave., Madison, WI 53792.

The risk of electromagnetic interference between microwave (MW) ablation and cardiac implantable electronic devices (CIEDs), ie, pacemakers and defibrillators, has not been fully evaluated. Fourteen MW ablations (kidney, n = 8; liver, n = 5; lung, n = 1) were performed in 13 patients with CIEDs in normal operating mode. Electrocardiography tracings, cardiovascular complications, tumor size, tumor-to-CIED distance, and tumor-to-device lead distance were recorded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2018.12.001DOI Listing
March 2019
2 Reads

Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE).

Eur Heart J 2019 Feb 21. Epub 2019 Feb 21.

Hospital Vall d`Hebron, Passeig de la Vall d'Hebron, Barcelona, Spain.

Aims: This trial aimed to evaluate the safety and efficiency of a common and simplified protocol for the surveillance of cardiac implantable electronic devices based on remote monitoring (RM) in patients with pacemakers (PMs) and implantable cardiac defibrillators (ICDs) for at least 24 months.

Methods And Results: The RM-ALONE is a multicentre prospective trial that randomly assigned 445 patients in two groups, both followed by RM: the home monitoring-only (HMo) based on RM + remote interrogations (RIs) every 6 months and the HM + IO that adds in-office evaluations every 6 months to RM. Four hundred and forty-five patients were enrolled in the study, 294 PMs and 151 ICDs recipients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz067DOI Listing
February 2019
3 Reads

Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Division of Cardiology, Rush University Medical Center, Chicago, Illinois.

Objectives: To define the national rate of complete heart block (CHB) after transcatheter aortic valve replacement (TAVR) and its impact on procedural mortality, overall cost, and length of hospital stay.

Background: CHB leading to permanent pacemaker (PPM) implantation is one of the most common complications post TAVR. National data on the temporal trend of CHB post TAVR are lacking. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28156DOI Listing
February 2019
2 Reads
2.107 Impact Factor

Sex Differences in Advanced Heart Failure Therapies.

Authors:
Eileen M Hsich

Circulation 2019 Feb;139(8):1080-1093

Heart and Vascular Institute at the Cleveland Clinic, OH. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, OH.

This in-depth review of sex differences in advanced heart failure therapy summarizes the existing literature on implantable cardioverter defibrillators, biventricular pacemakers, mechanical circulatory support, and transplantation with a focus on utilization, efficacy/clinical effectiveness, adverse events, and controversies. One will learn about the controversies regarding efficacy/clinical effectiveness of implantable cardioverter defibrillators and understand why these devices should be implanted in women even if there are sex differences in appropriate shocks. Individuals will learn about the sex differences with biventricular pacemakers with respect to ventricular remodeling and reduction in heart failure hospitalizations/mortality, as well as, possible mechanisms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383806PMC
February 2019

MRI for patients with cardiac implantable electronic devices: simplifying complexity with a 'one-stop' service model.

BMJ Qual Saf 2019 Feb 13. Epub 2019 Feb 13.

Department of Cardiac Imaging, Barts Heart Centre, Barts Health NHS Trust, London, UK.

Background: Patients with cardiac pacemakers and defibrillators are disadvantaged because of poor access to MRI scans, leading to late and misdiagnosis particularly for cancer and neurological disease. New technology allied to tested protocols now allows safe MRI scanning of such patients; however, logistical barriers persist.

Aim: To deliver a streamlined sustainable service that provides timely MRI scans to patients with cardiac implantable electronic devices (CIEDs). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjqs-2018-009079DOI Listing
February 2019
3 Reads

Contemporary management of cardiac implantable electronic device infection.

Heart 2019 Feb 12. Epub 2019 Feb 12.

Department of Cardiovascular Diseases, Mayo Clinic Arizona, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2017-312146
Publisher Site
http://dx.doi.org/10.1136/heartjnl-2017-312146DOI Listing
February 2019
2 Reads

Nursing Management for Patients Postoperative Cardiac Implantable Electronic Device Placement.

Authors:
Leanne H Fowler

Crit Care Nurs Clin North Am 2019 Mar 22;31(1):65-76. Epub 2018 Dec 22.

LSU Health New Orleans School of Nursing, 1900 Gravier Street, New Orleans, LA 70112, USA. Electronic address:

As cardiac implantable electronic devices (CIEDs) continue to evolve and patients continue to live longer, the use of these devices increases. CIEDs include permanent pacemakers, implanted cardioverter-defibrillators, and cardiac resynchronization therapy devices. Over the last 2 decades, the functionality of these devices has increased and can be complex. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cnc.2018.11.007DOI Listing
March 2019
2 Reads

Driving with Cardiac Devices in Australia. Does a review of recent evidence prompt a change in guidelines?

Intern Med J 2019 Feb 6. Epub 2019 Feb 6.

Victorian Institute of Forensic Medicine, Monash University.

Australian Driving Guidelines for patients with pacemakers and implanted cardioverter defibrillators are in line with many around the world, with some minor differences. Some aspects of these guidelines lack contemporary evidence in key decision making areas and make broad recommendations regarding groups with heterogeneous populations. Additionally, more recent studies suggest lower rates of adverse events in some patients with these devices than previously thought. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14243DOI Listing
February 2019
3 Reads

Outcomes in Patients with Left Ventricular Assist Devices, Pacemakers, and Implantable Cardioverter Defibrillators Undergoing Single Balloon Enteroscopy.

South Med J 2019 Feb;112(2):130-134

From the Departments of Digestive Diseases and Nutrition, Internal Medicine, and Evidence-Based Medicine and Research Outcomes, University of South Florida, Tampa.

Objectives: Obscure overt gastrointestinal bleeding can be challenging to evaluate in patients with electronic cardiac devices such as continuous flow left ventricular assist devices (LVADs), pacemakers (PPMs), and implantable cardioverter defibrillators (ICDs). Limited data exist on the utility and safety of single balloon enteroscopy (SBE) in patients with cardiac devices. We aimed to evaluate the safety, efficacy, diagnostic, and therapeutic outcomes of the aforementioned devices in patients undergoing SBE. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14423/SMJ.0000000000000938DOI Listing
February 2019
13 Reads

Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety.

J Am Heart Assoc 2019 Jan;8(2):e010869

3 Health Performance & Policy Research Unit Basil Hetzel Institute for Translational Research Woodville South South Australia.

Background To date, limited population-level studies have examined the impact of sex on the acute complications of cardiac implantable electronic devices ( CIED) , including permanent pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices. Methods and Results We studied all patients aged >18 years from 2010 to 2015 who were a resident of Australia or New Zealand, undergoing a new permanent pacemaker, implantable cardioverter defibrillator, or cardiac resynchronization therapy implant. Standardized variables were collected including patient demographic characteristics, primary and secondary diagnoses, procedures performed and discharge status. Read More

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/JAHA.118.010869
Publisher Site
http://dx.doi.org/10.1161/JAHA.118.010869DOI Listing
January 2019
10 Reads
2.882 Impact Factor

Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices.

Int J Cardiol 2019 Mar 4;279:72-78. Epub 2019 Jan 4.

Department of Cardiovascular Imaging, Barts Heart Centre, St Bartholomew's Hospital, London, UK; Institutes for Cardiovascular Science, University College London, London, UK. Electronic address:

Background: Myocardial scar assessment using late gadolinium enhancement Cardiovascular Magnetic Resonance (LGE CMR) is commonly indicated for patients with cardiac implantable electronic devices (CIEDs), however metal artifact can degrade images. We evaluated the clinical impact of LGE CMR incorporating a device-dependent metal artifact reduction strategy in patients with CIEDs.

Methods: 136 CMR studies were performed in 133 consecutive patients (age 56 ± 19 years, 69% male) with CIEDs (22% implantable loop recorders [ILRs], 40% permanent pacemakers [PPMs], 38% implantable cardioverter defibrillators [ICDs]; 42% non-MRI conditional) over 2 years, without complication. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2019.01.005DOI Listing
March 2019
6 Reads

The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles.

Int J Cardiol 2019 Mar 27;279:105-111. Epub 2018 Dec 27.

Department of Pathophysiology, Oita University, 1397-1, Yamane, Hidaka, Saitama 350-1298, Japan.

The most common cardiac feature of Kearns-Sayre syndrome (KSS) is atrioventricular block (AVB), and pacemaker implantations (PMIs) are recommended for KSS patients with advanced AVB. However, some KSS patients develop fatal arrhythmias such as polymorphic ventricular tachycardia (PMVT) and ventricular fibrillation (VF) and die suddenly even after PMIs. We report a patient with KSS who developed PMVT, VF, and QT prolongation, and was treated with mexiletine and successfully managed with an implantable cardioverter defibrillator (ICD). Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01675273183556
Publisher Site
http://dx.doi.org/10.1016/j.ijcard.2018.12.064DOI Listing
March 2019
20 Reads

New atrial fibrillation diagnosed by 30-day rhythm monitoring.

Am Heart J 2019 Mar 12;209:29-35. Epub 2018 Nov 12.

Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL. Electronic address:

Background: Recent studies of patients with pacemakers and implantable cardioverter/defibrillators have shown that subclinical atrial fibrillation (AF) is common and is associated with thromboembolic risk. We sought to evaluate the frequency, characteristics, and impact of new AF diagnosed by ambulatory 30-day rhythm monitoring.

Methods: The 30-day rhythm monitoring data from January 2010 to August 2015 at our institution were reviewed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2018.11.003DOI Listing
March 2019
3 Reads

Adherence to European Society of Gastrointestinal Endoscopy recommendations of endoscopists performing small bowel capsule endoscopy in Italy.

Dig Liver Dis 2018 Dec 10. Epub 2018 Dec 10.

Division of Oncological Gastroenterology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Background: The European Society of Gastrointestinal Endoscopy (ESGE) has recently issued a technical review focused on small bowel capsule endoscopy (SBCE).

Aim: To compare SBCE current practice in Italy to ESGE technical recommendations.

Material And Methods: A dedicated per-centre semi-quantitative questionnaire was prepared by a group of SBCE experts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.11.031DOI Listing
December 2018
3 Reads

Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study.

PLoS One 2019 2;14(1):e0206611. Epub 2019 Jan 2.

Manchester Heart Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.

Background: There are limited reports outlining the financial cost of treating cardiac implantable electronic device (CIED) infection outside the United States. This study aimed to determine the average treatment cost of CIED infection in a large UK tertiary referral centre and compared costs of different treatment pathways that are recognised in the management of CIED infection (early versus delayed re-implantation).

Methods: We retrospectively analysed cost and length of stay (LOS) data for consecutive patients undergoing infected CIED extraction with cardiac resynchronization therapy (CRT-D [with defibrillator], CRT-P [with pacemaker]), implantable cardioverter-defibrillators (ICDs) and permanent pacemakers (PPMs). Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0206611PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314621PMC
January 2019
3 Reads

Use of Administrative Data to Monitor Cardiac Implantable Electronic Device Complications.

Can J Cardiol 2019 Jan 13;35(1):100-103. Epub 2018 Nov 13.

Division of Cardiology, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.

Cardiac implantable electronic devices (CIEDs) are increasingly used in the Canadian population, because of expanding indications and an aging population. Device-related complications are a source of morbidity and mortality. There is currently no comprehensive monitoring strategy of CIED-related complications in Canada. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2018.10.018DOI Listing
January 2019
14 Reads

The Australian and New Zealand Cardiac Implantable Electronic Device Survey: Calendar Year 2017.

Heart Lung Circ 2019 Apr 11;28(4):560-566. Epub 2018 Dec 11.

Christchurch Hospital, Christchurch, New Zealand.

Background: A cardiac implantable electronic device (CIED) survey was undertaken in Australia and New Zealand for calendar year 2017 and involved pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs).

Results And Conclusions: For 2017, there were 17,971 (15,203 in 2013) new PMs sold in Australia and 1,811 (1,641 in 2013) implanted in New Zealand. The number of new PM implants per million population was 745 for Australia (652 in 2013) and 384 for New Zealand (367 in 2013). Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14439506183200
Publisher Site
http://dx.doi.org/10.1016/j.hlc.2018.11.018DOI Listing
April 2019
8 Reads

Use of the Metal Deletion Technique for Radiotherapy Planning in Patients with Cardiac Implantable Devices.

Klin Onkol 2018 ;31(6):434-438

Background: The number of cancer patients with cardiac implantable electronic devices receiving radiotherapy is increasing. Irradiation of such patients can cause malfunctions in pacemakers and implantable cardioverter-defibrillators. In this respect, it is necessary to make a proper irradiation plan for such cancer patients to minimize the dose received by both cardiac devices and pacing leads. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14735/amko2018434DOI Listing
January 2018
1 Read

Health-Related Quality of Life and Psychological Adjustment of Children and Adolescents with Pacemakers and Implantable Cardioverter Defibrillators: A Systematic Review.

Pediatr Cardiol 2019 Jan 11;40(1):1-16. Epub 2018 Dec 11.

Department of Cardiology, Pediatric Heart Centre, University Children's Hospital Zurich, Steinwiesstr. 75, 8032, Zurich, Switzerland.

The absence of cardiac symptoms, the improved exercise tolerance and the increased life expectancy are the advantages of a successful cardiac device therapy. Nevertheless, the fact of a lifelong device dependency, the inherent possibility of device malfunction and the progression of the underlying heart disease may impact the health-related quality of life (HRQoL) and the psychological adjustment of these individuals. To date, an overview of findings on these topics is lacking. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00246-018-2038-xDOI Listing
January 2019

Evaluation of the safety of users of active implantable medical devices (AIMD) in the working environment in terms of exposure to electromagnetic fields - Practical approach to the requirements of European Directive 2013/35/EU.

Int J Occup Med Environ Health 2018 12 5;31(6):795-808. Epub 2018 Nov 5.

Central Institute for Labour Protection - National Research Institute, Warszawa, Poland (Laboratory of Electromagnetic Hazards).

Objectives: Electromagnetic fields (EMF) may cause malfunctions in electronic devices, in particular in active implantable medical devices (AIMD), along with discomfort or health hazards to users. The use of AIMD by workers is increasing (especially cardiac pacemakers, implantable cardioverter defibrillators and wearable insulin infusion pumps). Electromagnetic fields may be much stronger in the working environment than applied in basic immunity tests of AIMD (based on EN 60601- 1-2:2015 and EN 50527-1:2016). Read More

View Article

Download full-text PDF

Source
http://www.journalssystem.com/ijomeh/AN-EVALUATION-OF-THE-SA
Publisher Site
http://dx.doi.org/10.13075/ijomeh.1896.00783DOI Listing
December 2018
25 Reads

Electrical Stun Gun and Modern Implantable Cardiac Stimulators.

Health Phys 2019 Jan;116(1):18-26

Italian National Institute of Health, Rome, Italy.

The aim of the study is to investigate systematically the possible interactions between two types of stun guns and last-generation pacemakers and implantable defibrillators. Experimental measurements were performed on pacemakers and implantable defibrillators from five leading manufacturers, considering the effect of stun gun dart positioning, sensing modality, stun gun shock duration, and defibrillation energy level. More than 300 measurements were collected. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HP.0000000000000942DOI Listing
January 2019
5 Reads

Effect of increasing heart rate on finger photoplethysmography fitness index (PPGF) in subjects with implanted cardiac pacemakers.

PLoS One 2018 28;13(11):e0207301. Epub 2018 Nov 28.

Centre of Advance Electronic & Communication Engineering (PAKET), Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia.

Finger photoplethysmography (PPG) is a noninvasive method that measures blood volume changes in the finger. The PPG fitness index (PPGF) has been proposed as an index of vascular risk and vascular aging. The objectives of the study were to determine the effects of heart rate (HR) on the PPGF and to determine whether PPGF is influenced by blood pressure (BP) changes. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0207301PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261569PMC
April 2019
1 Read

Contribution of Cardiac Implantable Electronic Devices to Thrombus Formation in Patients With Chronic Thromboembolic Pulmonary Hypertension.

JACC Clin Electrophysiol 2018 Nov 26;4(11):1431-1436. Epub 2018 Sep 26.

Division of Cardiovascular Medicine, University of California, San Diego, La Jolla, California. Electronic address:

Objectives: This study aimed to identify the prevalence of cardiac implantable electronic devices (CIEDs) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and to describe the associated disease burden.

Background: CTEPH is a debilitating disease, now potentially curable with pulmonary thromboendarterectomy (PTE). The contribution of CIEDs to thrombosis in this patient population has not been previously studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacep.2018.08.013DOI Listing
November 2018
12 Reads

Influence and safety of electronic apex locators in patients with cardiovascular implantable electronic devices: a systematic review.

Libyan J Med 2019 Dec;14(1):1547071

a College of Dentistry , Taibah University , Madinah Al Munawwarah , Saudi Arabia.

The widespread use of cardiovascular implantable electronic devices has increased concerns regarding using electronic apex locators in patients with these devices. This systematic review investigated the effects and safety of using electronic apex locators in patients with cardiovascular implantable electronic devices.

Methods: An electronic search in the Cochrane Library, PubMed (MEDLINE), ScienceDirect, and Scientific Electronic Library Online (Scielo) databases for relevant articles published between December 2000 and December 2018 was performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19932820.2018.1547071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249593PMC
December 2019
18 Reads

Shock to the heart: cardiac implantable devices' bad name in adults with tetralogy of Fallot.

Heart 2019 Apr 19;105(7):508-509. Epub 2018 Nov 19.

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2018-314235DOI Listing
April 2019
16 Reads

Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.

Authors:

Ont Health Technol Assess Ser 2018 24;18(7):1-199. Epub 2018 Oct 24.

Background: Under usual care, people with an implantable cardioverter-defibrillator (ICD), cardiac resynchronization therapy with or without a defibrillator (CRT-D and CRT-P, respectively), or a permanent pacemaker have follow-up in-person clinic visits. Remote monitoring of these devices allows the transfer of the information stored in the device so that it can be accessed by the clinic personnel via a secured website.

Methods: We completed a health technology assessment, which included an evaluation of clinical benefits and harms, value for money, and patient preferences for remote monitoring of ICDs, CRTs, and permanent pacemakers plus clinic visits compared with clinic visits alone. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235077PMC
January 2019
15 Reads

Cardiac and Vascular Injuries Sustained During Transvenous Lead Extraction.

Card Electrophysiol Clin 2018 12 5;10(4):651-657. Epub 2018 Oct 5.

University of Miami, Miller School of Medicine, 1295 Northwest 14 Street, Suite H, Miami, FL 33125, USA.

The rise in indications for cardiac implantable electronic devices has necessitated the development of tools for removal of the electrodes that connect the heart to these externally located pacemakers and defibrillators. After implant of a cardiac electrode, variable but progressive fibrous adhesion occurs. Removal of these adhesions can cause devastating complications with high risk of mortality if not treated surgically in a highly expeditious and appropriate manner. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18779182183008
Publisher Site
http://dx.doi.org/10.1016/j.ccep.2018.08.003DOI Listing
December 2018
13 Reads

Cardiac implantable electronic devices in adults with tetralogy of Fallot.

Heart 2019 Apr 30;105(7):538-544. Epub 2018 Oct 30.

Department of Cardiovascular Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA.

Background: Tachyarrhythmias and bradyarrhythmias affect 20%-50% of adult patients with tetralogy of Fallot (TOF) and some of these patients will require cardiac implantable electronic devices (CIED) such as pacemaker and/or internal cardioverter defibrillator.

Methods: The Mayo Adult Congenital Heart Disease database was queried for patients with repaired TOF and history of CIED implantation, 1990-2017. The study objectives were: (1) determine the occurrence of device-related complications defined as lead failure, lead recall, device infection and lead thrombus; and (2) determine the occurrence and risk factors for defibrillator shock. Read More

View Article

Download full-text PDF

Source
http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2018-314072
Publisher Site
http://dx.doi.org/10.1136/heartjnl-2018-314072DOI Listing
April 2019
3 Reads
5.595 Impact Factor

[New Innovative Pacemaker Devices - Leadless Pacemaker, Subcutaneous ICD].

Dtsch Med Wochenschr 2018 11 30;143(22):1617-1622. Epub 2018 Oct 30.

Conventional transvenous pacemaker and ICD-therapy is associated with significant lead- and pocket-related problems. Leadless pacemaker and subcutaneous ICD (S-ICD) therapies are innovative technologies, that avoid these complications. To date two leadless pacemaker systems have been implanted percutaneously for isolated right ventricular pacing, the Nanostim™ and the Micra™ device. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0560-3270DOI Listing
November 2018

[Troubleshooting in Patients with Implanted Pacemaker and ICD].

Dtsch Med Wochenschr 2018 11 30;143(22):1608-1616. Epub 2018 Oct 30.

Because of the growing number of implanted cardiac pacemakers and defibrillators and the ever-increasing complexity of these devices a fundamental knowledge of device malfunctions is of utmost importance even for the non-cardiology physician. Apart from hardware problems such as device infection, lead fracture or dislocation, basic knowledge of the pacemaker sensing and pacing algorithms is also necessary in order to judge the stimulation behavior in different clinical settings. With this respect, there are specific problems for antibradycardia and resynchronizing pacemakers as well as implantable defibrillators. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/a-0560-3180
Publisher Site
http://dx.doi.org/10.1055/a-0560-3180DOI Listing
November 2018
21 Reads

[Guideline-Based Indications on Pacing and ICD-Therapy].

Dtsch Med Wochenschr 2018 11 30;143(22):1599-1607. Epub 2018 Oct 30.

In 2016, there were 77 293 pacemakers and 28 953 ICDs implanted in Germany. This makes pacemaker- and ICD-implantations part of the most frequently performed operations in Germany. This article addresses questions of correct indication and patient selection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0579-5002DOI Listing
November 2018

Nanostim-leadless pacemaker.

Herzschrittmacherther Elektrophysiol 2018 Dec 19;29(4):327-333. Epub 2018 Oct 19.

Abteilung für Kardiologie/Elektrophysiologie, Kerckhoff-Klinik GmbH, Benekestr. 2-8, 61231, Bad Nauheim, Germany.

Nanostim™ (St. Jude Medical Inc., Saint Paul, MN, USA; now Abbott Medical Inc. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00399-018-0598-3
Publisher Site
http://dx.doi.org/10.1007/s00399-018-0598-3DOI Listing
December 2018
6 Reads

Early-BYRD: alternative early pacing and defibrillation lead replacement avoiding venous puncture.

J Cardiothorac Surg 2018 Oct 3;13(1):102. Epub 2018 Oct 3.

Department of Cardiothoracic Surgery, University Medical Center Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.

Background: In cases of lead failure after implantation of pacemakers (PM) or implantable cardioverter defibrillators (ICD) early lead replacement may be challenging. Puncture of the subclavian vein bears possible complications such as pneumothorax, hematothorax, and damage of leads to be left in place. To avoid venous puncture PM or ICD leads were replaced using a flexible polypropylene sheath (Byrd-sheath). Read More

View Article

Download full-text PDF

Source
https://cardiothoracicsurgery.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/s13019-018-0795-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169062PMC
October 2018
4 Reads

Individual programming of current multiprogrammable pacemakers : Still unsatisfactory?

Herz 2018 Sep 25. Epub 2018 Sep 25.

Department of Cardiology, Vivantes Klinikum im Friedrichshain und Am Urban, Berlin, Germany.

Background: Pacemaker (PM) technology has developed tremendously in recent decades. We evaluated the extent of individual programming in current PMs.

Methods: Over a 7-month period in 2016, all deceased persons taken to the Rostock crematorium were prospectively screened for cardiac implantable electronic devices (CIEDs) and these were interrogated in situ. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00059-018-4753-8DOI Listing
September 2018
21 Reads

Treatment planning and dental technology for patients with implanted cardiac devices.

Authors:
Amber D Riley

Gen Dent 2018 Sep-Oct;66(5):56-60

Implantable cardiac devices are increasingly common in the dental patient population. These devices include cardiac pacemakers, implantable cardioverters-defibrillators, and combination designs. To safely follow through with treatment, the clinician first must identify the patient's underlying medical condition warranting the device and consider the condition as well as the device in determining diagnosis, drug selection, appointment length, follow-up, and outcome expectations. Read More

View Article

Download full-text PDF

Source
February 2019
3 Reads

Soft Tissue and Skin Reinforcement with Acellular Dermal Matrix to Protect Implanted Cardioverters/Defibrillators and Pacemakers.

Plast Reconstr Surg Glob Open 2018 Jul 13;6(7):e1866. Epub 2018 Jul 13.

Division of Cardiology, Scripps Clinic, La Jolla, Calif.

Cardiac pacemakers and implantable cardioverters/defibrillators are often placed in older patients with thin skin and scanty subcutaneous tissue. These devices and cardiac leads are at risk for progressive skin erosion and exposure leading to infection. To prevent this severe complication, we developed a reinforcing insertion of acellular dermal matrix. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GOX.0000000000001866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110691PMC
July 2018
1 Read

[Management of patients with pacemakers or implantable cardioverter defibrillator undergoing radiotherapy].

Cancer Radiother 2018 Oct 25;22(6-7):515-521. Epub 2018 Aug 25.

Service de radiothérapie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75908 Paris cedex 15, France.

An increasing number of patients with cardiac implantable electronic devices benefit from radiotherapy, warranting specific collaborative management between both radiation oncologists and cardiologists. Interactions between electromagnetic fields, secondary particles and cardiac implantable electronic devices may result in transient and reversible malfunctions with significant consequences depending on the underlying cardiac pathology and the level of patient's cardiac implantable electronic devices dependency. Numerous international guidelines on patients' management have been proposed and all agree on a total cumulated dose limit at the battery of 5Gy and on the need for an initial as well as repeated evaluation over time, up to 6months after the last radiation. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S12783218183026
Publisher Site
http://dx.doi.org/10.1016/j.canrad.2018.06.017DOI Listing
October 2018
11 Reads

Assessment of the Safety Risk of Dermatoscope Magnets in Patients With Cardiovascular Implanted Electronic Devices.

JAMA Dermatol 2018 Oct;154(10):1204-1207

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Hauppauge, New York.

Importance: Cardiovascular implanted electronic devices (CIEDs) are susceptible to electromagnetic interference. Dermatologists regularly use devices containing magnets, including dermatoscopes and their attachments, which could pose a hazard to patients with CIEDs.

Objective: To investigate the safety risk of magnets in dermatoscopes to patients with CIEDs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2018.2531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233742PMC
October 2018
15 Reads

Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trial.

Pacing Clin Electrophysiol 2018 11 19;41(11):1476-1480. Epub 2018 Sep 19.

Campus Bio-Medico, Unit of Cardiology, University of Rome, Rome, Italy.

Background: Many patients requiring cardiac implantable electronic device (CIED) implantation are on long-term oral anticoagulant therapy. While continuation of warfarin has been shown to be safe and reduce bleeding complications compared to interruption of warfarin therapy and heparin bridging, it is not known which novel oral anticoagulants (NOAC) regimen (interrupted vs uninterrupted) is better in this setting.

Methods: One-hundred and one patients were randomized to receive CIED implantation with either interrupted or uninterrupted/continuous NOAC therapy before surgery. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pace.13482
Publisher Site
http://dx.doi.org/10.1111/pace.13482DOI Listing
November 2018
13 Reads

Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes.

Nucleus 2018 ;9(1):442-459

c CNR Institute of Molecular Genetics , Unit of Bologna , Bologna , Italy.

Lamin A/C gene mutations can be associated with cardiac diseases, usually referred to as 'cardiolaminopathies' characterized by arrhythmic disorders and/or left ventricular or biventricular dysfunction up to an overt picture of heart failure. The phenotypic cardiac manifestations of laminopathies are frequently mixed in complex clinical patterns and specifically may include bradyarrhythmias (sinus node disease or atrioventricular blocks), atrial arrhythmias (atrial fibrillation, atrial flutter, atrial standstill), ventricular tachyarrhythmias and heart failure of variable degrees of severity. Family history, physical examination, laboratory findings (specifically serum creatine phosphokinase values) and ECG findings are often important 'red flags' in diagnosing a 'cardiolaminopathy'. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19491034.2018.1506680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244733PMC
January 2018
8 Reads